About Us Medicines & Focus Research & Development Responsibility Investors News & Events Careers About Us Focused on Critical Unmet Needs Discover Alkermes Alkermes is focused on developing innovative medicines that aim to address unmet needs of people living with serious mental illness, addiction and cancer. As a fully-integrated global biopharmaceutical company, we apply our scientific expertise and proprietary technologies to develop products that are designed to make a meaningful difference in the way people manage their diseases. Beyond our central mission to develop medicines, we believe in championing approaches to treatment that account for the multitude of factors that affect outcomes for patients, caregivers and communities. In addition to our scientific pursuits, we are committed to patient engagement, disease education and awareness and advocacy for important policies that support equitable access to treatment options. We believe that being a positive force for change begins when we dare to expect more – of medicines, of our healthcare system and of ourselves – as we seek to reset expectations of what constitutes successful management of complex diseases. Our Purpose & Values Our core values and our commitment to helping improve the lives of people living with serious mental illness, addiction and cancer guide and define our culture. With collaboration at our core, we strive to value every person and respect each voice. We are beyond passionate. Our commitment to our employees and the many people and communities we serve keeps us moving forward every day. Your browser does not support the video tag. We are united in our mission to pursue great science with deep compassion as we strive to make a real impact on the lives of patients, families and communities. Meet our leadership team Diversity, Inclusion & Belonging Alkermes is committed to diversity, inclusion and belonging (DIB) in various aspects of our business. We strive to foster an environment of equality and compassion, where all voices are respected and valued. It is important to our mission and our ethos as an organization that we attract and retain diverse candidates and perspectives. We recently established a DIB Executive Committee to focus on assessing our current DIB efforts and expanding upon them and other such efforts in the future. Our belief in the importance of DIB extends beyond our employees; we are committed to advancing diversity and inclusion in our clinical trials, seeking out diverse suppliers, and supporting organizations that share our commitment to equity and inclusion in our healthcare system and our communities. Learn more Collaborations We have collaborative arrangements with leading pharmaceutical companies and research institutions for the development, manufacture and commercialization of innovative medicines. Developing new partnerships remains a key strategy for Alkermes. We bring scientific excellence, deep product development expertise and a unique capacity to identify and address opportunities across a variety of disease states. Connect with our Business Development team Locations Our U.S. corporate offices and R&D facilities are located in Waltham, Massachusetts, and our Global Headquarters is located in Dublin, Ireland. We have GMP manufacturing facilities in Wilmington, Ohio and Athlone, Ireland. Contact us U.S. Corporate Offices and R&D Waltham, MA Manufacturing Wilmington, OH Global Headquarters Dublin, Ireland Manufacturing and R&D Athlone, Ireland Contact Us Terms of Use Privacy Policy Sitemap © 2021 Alkermes. All rights reserved. Close Please review our Privacy Policy. By using our website without changing your cookie settings you agree to our use of Cookies as described in our Privacy Policy. Learn more